1988
DOI: 10.1016/0006-2952(88)90553-9
|View full text |Cite
|
Sign up to set email alerts
|

Organspecific, qualitative changes in the phospholipid composition of rats after chronic administration of the antidepressant drug desipramine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

1989
1989
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(8 citation statements)
references
References 18 publications
0
8
0
Order By: Relevance
“…The lipid content of the brain is considerably higher than in other organs (Moor et al, 1988) and experimental evidence gathered in various animals and humans points to a dierential lipid content and composition in the grey and the white matters of the brain (Chavko et al, 1993;SoÈ derberg et al, 1990;Zhang et al, 1996). Total lipid content in the white matter is twice as high as in the grey matter.…”
Section: Introductionmentioning
confidence: 99%
“…The lipid content of the brain is considerably higher than in other organs (Moor et al, 1988) and experimental evidence gathered in various animals and humans points to a dierential lipid content and composition in the grey and the white matters of the brain (Chavko et al, 1993;SoÈ derberg et al, 1990;Zhang et al, 1996). Total lipid content in the white matter is twice as high as in the grey matter.…”
Section: Introductionmentioning
confidence: 99%
“…The increase in membrane fluidity potentiates the turnover of enzymatic processes (Gavish & Werber 1989) as well as the rate of lateral encounters (Hanski et a1 1979) which, in turn, might facilitate the methylation of the membrane phospholipid. Although the modulation of phospholipid methylation by altering the level of the substrate (phosphatidylethanolamine) by imipramine cannot be excluded, the results of others (Lullmann-Rauch 1979; Honegger et al 1983; Moor et al 1988) indicate that only prolonged exposure of the tissue to imipramine or to other amphiphilic cationic agents led to phospholipidosis in the membrane.…”
Section: Regionmentioning
confidence: 98%
“…Treatment of rats with imipramine for fourteen days produced changes in the sensitivity of phospholipid methyltransferases to the stimulating effect of imipramine, since 5 x M imipramine added externally to the incubation mixture did not potentiate the phospholipid methylation in the synaptic cortical membranes of rats treated chronically with imipramine. Lullmann-Rauch (1979) and Moor et al (1988) have shown that-in contrast to short time expo-sure-long-term treatment with imipramine or desipramine led to the accumulation of phospholipid and induced marked differences in the phospholipid content of various tissues. Therefore, we cannot exclude the possibility that chronic exposure of rats to imipramine might decrease the level of substrate (phosphatidylethanolamine) or increase the level of the product (phosphatidylcholine) in the cortical membranes of rats and this could inhibit the stimulating effect of externally added imipramine.…”
Section: Regionmentioning
confidence: 99%
“…Indeed, Sklair-Tavron and Nestler [39] have shown that BDNF increases the survival and growth of hippocampal neurons. Animal studies have shown that imipramine antidepressants and their derivatives can behave as compounds that interact with G proteins [40]. Thus, it is plausible to hypothesize that depression could be considered a disorder of the super family of G-proteins coupled to a receptor.…”
Section: Antidepressant Action On Second Messengers and Genesmentioning
confidence: 99%